Allergan Eyes Posurdex In Oculex Buy; Edema Approval Could Come In 2006
Executive Summary
Allergan could enter the retinal therapy market in late 2006 with Oculex' macular edema implant Posurdex following its $230 mil. acquisition of the technology company